AU2001255349A1 - Fyn kinase as a target for modulation of integrin mediated signal transduction - Google Patents

Fyn kinase as a target for modulation of integrin mediated signal transduction

Info

Publication number
AU2001255349A1
AU2001255349A1 AU2001255349A AU5534901A AU2001255349A1 AU 2001255349 A1 AU2001255349 A1 AU 2001255349A1 AU 2001255349 A AU2001255349 A AU 2001255349A AU 5534901 A AU5534901 A AU 5534901A AU 2001255349 A1 AU2001255349 A1 AU 2001255349A1
Authority
AU
Australia
Prior art keywords
modulation
target
signal transduction
mediated signal
fyn kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255349A
Inventor
Kyra J. Cowan
Debbie A. Law
David R Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of AU2001255349A1 publication Critical patent/AU2001255349A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001255349A 2000-04-14 2001-04-13 Fyn kinase as a target for modulation of integrin mediated signal transduction Abandoned AU2001255349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19740300P 2000-04-14 2000-04-14
US60197403 2000-04-14
PCT/US2001/012039 WO2001079144A2 (en) 2000-04-14 2001-04-13 Fyn kinase as a target for modulation of integrin mediated signal transduction

Publications (1)

Publication Number Publication Date
AU2001255349A1 true AU2001255349A1 (en) 2001-10-30

Family

ID=22729274

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255349A Abandoned AU2001255349A1 (en) 2000-04-14 2001-04-13 Fyn kinase as a target for modulation of integrin mediated signal transduction

Country Status (2)

Country Link
AU (1) AU2001255349A1 (en)
WO (1) WO2001079144A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838244B2 (en) 2004-03-24 2010-11-23 Auckland Uniservices Limited SET1 proteins and uses thereof
US8057815B2 (en) * 2004-04-19 2011-11-15 Portola Pharmaceuticals, Inc. Methods of treatment with Syk inhibitors
JP2008512111A (en) 2004-09-09 2008-04-24 オークランド ユニサービシズ リミテッド Novel peptides and methods for the treatment of inflammatory diseases
WO2006112739A1 (en) * 2005-04-19 2006-10-26 Auckland Uniservices Limited Novel peptides and methods for the treatment of inflammatory disorders
EP2068877A4 (en) * 2006-07-19 2011-09-21 Cleveland Clinic Foundation Compounds and methods of modulating angiogenesis
US8563690B2 (en) 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CA2835806A1 (en) * 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753687A (en) * 1995-06-19 1998-05-19 Ontogen Corporation Modulators of proteins with phosphotryrosine recognition units
NZ321304A (en) * 1995-10-18 2000-08-25 Cor Therapeutics Inc Methods of identifying signalling partners in phosphorylation of cytoplasmic tyrosine residues in the beta subunit of integrins
NZ335932A (en) * 1996-11-21 2001-03-30 Cor Therapeutics Inc Use of a peptide agent such as a diphosphorylated peptide to modulate the interactions between myosin and integrins

Also Published As

Publication number Publication date
WO2001079144A2 (en) 2001-10-25
WO2001079144A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001265259A1 (en) Distance/ranging by determination of rf phase delta
AU3771100A (en) Synthesis of epothilones
AU2001237041A1 (en) Kinase inhibitors
AU2002361703A1 (en) Fast acquisition of a gps signal
AU2002239370A1 (en) Signal tampon
AU3529800A (en) Antisense modulation of interleukin-5 signal transduction
AU6471300A (en) P38map kinase inhibitors
AU2002227441A1 (en) Biocompatible adhesives
AU2002221047A1 (en) Quinazolinone derivatives
AU2002223589A1 (en) Production of polypropylene
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU6111000A (en) Inhibitors of viral helcase
AU2001285971A1 (en) Measurement of paper or board
AU2002216314A1 (en) Heterocyclic angiogenesis inhibitors
AU2002317367A1 (en) Predistorting of contention signals
AU2001243615A1 (en) Secure tracking of articles
AU2001255349A1 (en) Fyn kinase as a target for modulation of integrin mediated signal transduction
AU2001288360A1 (en) Genomics-assisted rapid identification of targets
AU2001232106A1 (en) Frequency synthesiser
AU2001276549A1 (en) Transglutaminase for inhibiting angiogenesis
AU2001266081A1 (en) Improvement of itraconazole bioavailability
AU2001251259A1 (en) Novel signal transduction molecules
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
AU4288900A (en) Production of polyethylene
AU2002247063A1 (en) Antisense modulation of casein kinase 2-beta expression